Epigenetic regulation is a novel approach to cancer treatment. Inhibition of enhancer of zeste homolog 2 () is a method to provide targeted epigenetic regulation. Tazemetostat is a first-in-class targeted epigenetic regulator that specifically inhibits EZH2.
View Article and Find Full Text PDF